Data Integrity Issues In Bioequivalence Studies

Nilufer Tampal, PhD, Acting Deputy Director of the Office of

CDER's Director of the Division of Generic Drug

Victoria Keck, MS, VMD, Division of Clinical Review, discusses types of

Drugmaker Wockhardt's pending regulatory

... Former Deputy Commissioner of USFDA says that while qualitatively there has been an improvement in

In this video, we dive into one of the core pillars of

On October 20, 2017, Regis Technologies hosted a seminar on "Understanding

On October 20, 2017, Regis Technologies hosted a seminar on "Understanding

This webinar from NSF expert George Toscano covers the trends and priorities when assuring

Boost Your Pharma Knowledge with Our Exclusive

Data Integrity

MHRA's Expert GCP Inspector Gail Francis discusses how to approach

Half of all warning letters by the FDA cite

Do you know the main cause of

For more details you can go though this link for our newsletter on PharmaProfs- https://rb.gy/tszx69

In our introduction to

Sean Kassim, PhD, Director of Office of Study

On October 20, 2017, Regis Technologies hosted a seminar on "Understanding

All India Drugs Control Officers Confederation.

MHRA's Lead Senior GCP Inspector Andy Fisher discusses